ArrowMark Colorado Holdings’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-117,306
Closed -$7.29M 338
2023
Q4
$7.29M Buy
117,306
+6,195
+6% +$154K 0.08% 174
2023
Q3
$2.47M Buy
+111,111
New +$2.33M 0.03% 226

ArrowMark Colorado Holdings's RYZB Position: Q1 2024 in Review

ArrowMark Colorado Holdings sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 117,306 shares — an estimated $7.29M sold.

ArrowMark Colorado Holdings first reported a position in RYZB in Q3 2023 and held it in 2 quarters. The position peaked at $7.29M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

  • ArrowMark Colorado Holdings reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • ArrowMark Colorado Holdings sold 117,306 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $7.29M.
  • ArrowMark Colorado Holdings first reported a position in RayzeBio, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
  • ArrowMark Colorado Holdings's RayzeBio, Inc. Common Stock position peaked at $7.29M in Q4 2023.
  • 0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on ArrowMark Colorado Holdings's 13F filing for Q1 2024, filed 15 May 2024.